{"prime":"con","number_set":{"balancesheet":[["Share Capital",{"2008-03-31":24.87,"2016-03-31":28.22,"2014-03-31":27.12,"2011-03-31":27.03,"2015-03-31":27.13,"2013-03-31":27.09,"2006-03-31":43.75,"2012-03-31":27.05,"2017-03-31":28.22,"2010-03-31":26.98,"2009-03-31":25.05,"2007-03-31":24.01}],["Reserves",{"2008-03-31":1003.38,"2016-03-31":7337.75,"2014-03-31":2878.9,"2011-03-31":1952.71,"2015-03-31":4924.92,"2013-03-31":2496.09,"2006-03-31":275.01,"2012-03-31":2158.66,"2017-03-31":9408.4,"2010-03-31":1746.43,"2009-03-31":1204.92,"2007-03-31":426.15}],["Borrowings",{"2008-03-31":527.62,"2016-03-31":787.42,"2014-03-31":353.32,"2011-03-31":1143.12,"2015-03-31":410.1,"2013-03-31":580.65,"2006-03-31":728.67,"2012-03-31":489.16,"2017-03-31":2776.53,"2010-03-31":759.76,"2009-03-31":1065.91,"2007-03-31":908.74}],["Other Liabilities",{"2008-03-31":379.5,"2016-03-31":2147.87,"2014-03-31":980.51,"2011-03-31":251.35,"2015-03-31":2313.52,"2013-03-31":792.41,"2006-03-31":180.49,"2012-03-31":504.0,"2017-03-31":2013.95,"2010-03-31":243.39,"2009-03-31":280.32,"2007-03-31":266.3}],["Total Liabilities",{"2008-03-31":1935.37,"2016-03-31":10301.26,"2014-03-31":4239.85,"2011-03-31":3374.21,"2015-03-31":7675.67,"2013-03-31":3896.24,"2006-03-31":1207.92,"2012-03-31":3178.87,"2017-03-31":14227.1,"2010-03-31":2776.56,"2009-03-31":2576.2,"2007-03-31":1625.2}],["Fixed Assets",{"2008-03-31":367.53,"2016-03-31":1438.0,"2014-03-31":448.52,"2011-03-31":223.78,"2015-03-31":1230.68,"2013-03-31":275.66,"2006-03-31":252.56,"2012-03-31":223.76,"2017-03-31":1596.37,"2010-03-31":190.41,"2009-03-31":172.81,"2007-03-31":276.91}],["CWIP",{"2008-03-31":225.57,"2016-03-31":276.06,"2014-03-31":83.31,"2011-03-31":33.59,"2015-03-31":294.19,"2013-03-31":172.42,"2006-03-31":57.56,"2012-03-31":68.94,"2017-03-31":270.66,"2010-03-31":46.88,"2009-03-31":32.45,"2007-03-31":156.3}],["Investments",{"2008-03-31":196.7,"2016-03-31":1858.43,"2014-03-31":1409.24,"2011-03-31":1041.25,"2015-03-31":1659.52,"2013-03-31":1294.33,"2006-03-31":43.56,"2012-03-31":1083.27,"2017-03-31":1866.7,"2010-03-31":992.92,"2009-03-31":237.63,"2007-03-31":139.1}],["Other Assets",{"2008-03-31":1145.57,"2016-03-31":6728.77,"2014-03-31":2298.78,"2011-03-31":2075.59,"2015-03-31":4491.28,"2013-03-31":2153.83,"2006-03-31":854.24,"2012-03-31":1802.9,"2017-03-31":10493.37,"2010-03-31":1546.35,"2009-03-31":2133.31,"2007-03-31":1052.89}],["Total Assets",{"2008-03-31":1935.37,"2016-03-31":10301.26,"2014-03-31":4239.85,"2011-03-31":3374.21,"2015-03-31":7675.67,"2013-03-31":3896.24,"2006-03-31":1207.92,"2012-03-31":3178.87,"2017-03-31":14227.1,"2010-03-31":2776.56,"2009-03-31":2576.2,"2007-03-31":1625.2}]],"annual":[["Sales",{"2008-03-31":1404.82,"2016-03-31":6115.17,"2014-03-31":2393.86,"2011-03-31":1162.94,"2015-03-31":5085.6,"2013-03-31":2025.38,"2006-03-31":618.44,"2012-03-31":1564.67,"2017-03-31":7989.23,"2010-03-31":983.03,"2009-03-31":866.17,"2007-03-31":837.12}],["Expenses",{"2008-03-31":923.15,"2016-03-31":4349.89,"2014-03-31":1897.9,"2011-03-31":877.16,"2015-03-31":3789.34,"2013-03-31":1692.94,"2006-03-31":515.18,"2012-03-31":1253.69,"2017-03-31":5327.04,"2010-03-31":819.79,"2009-03-31":645.38,"2007-03-31":626.18}],["Operating Profit",{"2008-03-31":481.67,"2016-03-31":1765.28,"2014-03-31":495.96,"2011-03-31":285.78,"2015-03-31":1296.26,"2013-03-31":332.44,"2006-03-31":103.26,"2012-03-31":310.98,"2017-03-31":2662.19,"2010-03-31":163.24,"2009-03-31":220.79,"2007-03-31":210.94}],["OPM",{"2008-03-31":34.29,"2016-03-31":28.87,"2014-03-31":20.72,"2011-03-31":24.57,"2015-03-31":25.49,"2013-03-31":16.41,"2006-03-31":16.7,"2012-03-31":19.88,"2017-03-31":33.32,"2010-03-31":16.61,"2009-03-31":25.49,"2007-03-31":25.2}],["Other Income",{"2008-03-31":22.56,"2016-03-31":117.28,"2014-03-31":67.13,"2011-03-31":71.75,"2015-03-31":84.94,"2013-03-31":116.25,"2006-03-31":16.94,"2012-03-31":55.1,"2017-03-31":148.24,"2010-03-31":78.7,"2009-03-31":139.16,"2007-03-31":22.67}],["Interest",{"2008-03-31":43.64,"2016-03-31":36.22,"2014-03-31":30.98,"2011-03-31":85.75,"2015-03-31":30.19,"2013-03-31":43.69,"2006-03-31":17.45,"2012-03-31":60.87,"2017-03-31":152.6,"2010-03-31":99.67,"2009-03-31":94.81,"2007-03-31":39.36}],["Depreciation",{"2008-03-31":29.44,"2016-03-31":99.81,"2014-03-31":30.2,"2011-03-31":20.99,"2015-03-31":119.46,"2013-03-31":25.04,"2006-03-31":17.48,"2012-03-31":21.11,"2017-03-31":104.93,"2010-03-31":21.28,"2009-03-31":19.1,"2007-03-31":23.46}],["Profit before tax",{"2008-03-31":431.15,"2016-03-31":1746.53,"2014-03-31":501.92,"2011-03-31":250.79,"2015-03-31":1231.55,"2013-03-31":379.96,"2006-03-31":85.27,"2012-03-31":284.1,"2017-03-31":2552.9,"2010-03-31":120.99,"2009-03-31":246.04,"2007-03-31":170.79}],["Tax",{"2008-03-31":42.13,"2016-03-31":262.27,"2014-03-31":68.11,"2011-03-31":38.61,"2015-03-31":224.02,"2013-03-31":-6.15,"2006-03-31":17.97,"2012-03-31":18.8,"2017-03-31":412.28,"2010-03-31":-7.47,"2009-03-31":28.11,"2007-03-31":35.99}],["Net Profit",{"2008-03-31":389.02,"2016-03-31":1484.27,"2014-03-31":433.82,"2011-03-31":212.18,"2015-03-31":1007.53,"2013-03-31":386.11,"2006-03-31":67.3,"2012-03-31":265.3,"2017-03-31":2140.61,"2010-03-31":128.46,"2009-03-31":217.93,"2007-03-31":134.8}],["EPS (unadj)",{"2008-03-31":15.53,"2016-03-31":52.6,"2014-03-31":15.66,"2011-03-31":7.78,"2015-03-31":36.72,"2013-03-31":13.92,"2006-03-31":5.43,"2012-03-31":9.48,"2017-03-31":75.86,"2010-03-31":4.69,"2009-03-31":8.63,"2007-03-31":11.05}],["Dividend Payout",{"2008-03-31":4.48,"2016-03-31":3.8,"2014-03-31":12.5,"2011-03-31":5.1,"2015-03-31":5.39,"2013-03-31":14.03,"2006-03-31":12.35,"2012-03-31":20.39,"2017-03-31":2.64,"2010-03-31":8.4,"2009-03-31":4.6,"2007-03-31":7.13}]],"cashflow":[["Cash from Operating Activity",{"2008-03-31":246.67,"2016-03-31":354.75,"2014-03-31":114.24,"2011-03-31":421.06,"2015-03-31":145.11,"2013-03-31":253.02,"2006-03-31":-25.49,"2012-03-31":194.65,"2017-03-31":877.72,"2010-03-31":983.16,"2009-03-31":94.06,"2007-03-31":-8.83}],["Cash from Investing Activity",{"2008-03-31":-15.7,"2016-03-31":-1545.08,"2014-03-31":210.75,"2011-03-31":-654.72,"2015-03-31":-176.46,"2013-03-31":-119.3,"2006-03-31":-239.08,"2012-03-31":601.53,"2017-03-31":-2580.46,"2010-03-31":-1000.22,"2009-03-31":-589.17,"2007-03-31":-237.92}],["Cash from Financing Activity",{"2008-03-31":-231.18,"2016-03-31":1222.55,"2014-03-31":-384.67,"2011-03-31":259.4,"2015-03-31":-32.39,"2013-03-31":-13.77,"2006-03-31":244.45,"2012-03-31":-779.72,"2017-03-31":1879.38,"2010-03-31":10.45,"2009-03-31":495.62,"2007-03-31":168.98}],["Net Cash Flow",{"2008-03-31":-0.21,"2016-03-31":32.23,"2014-03-31":-59.68,"2011-03-31":25.74,"2015-03-31":-63.74,"2013-03-31":119.95,"2006-03-31":-20.12,"2012-03-31":16.46,"2017-03-31":176.64,"2010-03-31":-6.61,"2009-03-31":0.51,"2007-03-31":-77.77}]],"quarters":[["Sales",{"2016-06-30":1667.2,"2016-12-31":2191.78,"2017-03-31":2065.09,"2017-06-30":1547.78,"2015-06-30":1247.81,"2015-03-31":3118.72,"2017-09-30":1659.81,"2015-12-31":1416.27,"2016-03-31":1931.18,"2017-12-31":1556.55,"2016-09-30":2171.44,"2015-09-30":1600.31}],["Expenses",{"2016-06-30":1066.29,"2016-12-31":1347.37,"2017-03-31":1629.44,"2017-06-30":1194.84,"2015-06-30":818.85,"2015-03-31":2202.87,"2017-09-30":1262.36,"2015-12-31":1066.02,"2016-03-31":1415.9,"2017-12-31":1289.75,"2016-09-30":1390.21,"2015-09-30":1129.53}],["Operating Profit",{"2016-06-30":600.91,"2016-12-31":844.41,"2017-03-31":435.65,"2017-06-30":352.94,"2015-06-30":428.96,"2015-03-31":915.85,"2017-09-30":397.45,"2015-12-31":350.25,"2016-03-31":515.28,"2017-12-31":266.8,"2016-09-30":781.23,"2015-09-30":470.78}],["OPM",{"2016-06-30":36.04,"2016-12-31":38.53,"2017-03-31":21.1,"2017-06-30":22.8,"2015-06-30":34.38,"2015-03-31":29.37,"2017-09-30":23.95,"2015-12-31":24.73,"2016-03-31":26.68,"2017-12-31":17.14,"2016-09-30":35.98,"2015-09-30":29.42}],["Other Income",{"2016-06-30":97.93,"2016-12-31":106.36,"2017-03-31":-50.25,"2017-06-30":42.59,"2015-06-30":26.04,"2015-03-31":39.07,"2017-09-30":56.3,"2015-12-31":-2.99,"2016-03-31":66.92,"2017-12-31":37.23,"2016-09-30":-5.8,"2015-09-30":27.32}],["Depreciation",{"2016-06-30":25.48,"2016-12-31":26.34,"2017-03-31":27.32,"2017-06-30":29.94,"2015-06-30":23.55,"2015-03-31":95.15,"2017-09-30":28.89,"2015-12-31":25.15,"2016-03-31":26.06,"2017-12-31":29.55,"2016-09-30":25.8,"2015-09-30":25.05}],["Interest",{"2016-06-30":11.04,"2016-12-31":49.54,"2017-03-31":49.72,"2017-06-30":45.74,"2015-06-30":8.25,"2015-03-31":6.85,"2017-09-30":47.44,"2015-12-31":8.35,"2016-03-31":10.26,"2017-12-31":47.0,"2016-09-30":42.31,"2015-09-30":9.36}],["Profit before tax",{"2016-06-30":662.32,"2016-12-31":874.89,"2017-03-31":308.36,"2017-06-30":319.85,"2015-06-30":423.21,"2015-03-31":852.92,"2017-09-30":377.43,"2015-12-31":313.76,"2016-03-31":545.87,"2017-12-31":227.48,"2016-09-30":707.33,"2015-09-30":463.69}],["Tax",{"2016-06-30":143.51,"2016-12-31":163.58,"2017-03-31":-48.7,"2017-06-30":49.01,"2015-06-30":84.64,"2015-03-31":182.49,"2017-09-30":49.55,"2015-12-31":50.58,"2016-03-31":34.16,"2017-12-31":33.36,"2016-09-30":151.5,"2015-09-30":91.52}],["Net Profit",{"2016-06-30":518.81,"2016-12-31":711.31,"2017-03-31":357.06,"2017-06-30":270.84,"2015-06-30":338.57,"2015-03-31":670.43,"2017-09-30":327.88,"2015-12-31":263.18,"2016-03-31":511.72,"2017-12-31":194.12,"2016-09-30":555.83,"2015-09-30":372.17}]]},"bse_code":"532296","short_name":"Glenmark Pharma.","nse_code":"GLENMARK","companyrating_set":[{"rating__rating":"CRISIL A1+","instrument":"Bank Guarantee limit","rating__source":"crisil","link":"http://www.crisil.com/ratings/company-wise-ratings.jsp?txtSearch=Glenmark Pharmaceuticals Ltd"},{"rating__rating":"CRISIL AA- (Negative)","instrument":"Cash Credit Limit","rating__source":"crisil","link":"http://www.crisil.com/ratings/company-wise-ratings.jsp?txtSearch=Glenmark Pharmaceuticals Ltd"},{"rating__rating":"BWR CG 3","instrument":"Corporate Governance Quality","rating__source":"brickworks","link":"http://google.com/search?btnI=1&q=Glenmark Pharmaceuticals Ltd+site:brickworkratings.com"},{"rating__rating":"CRISIL A1+","instrument":"Letter of Credit Limit","rating__source":"crisil","link":"http://www.crisil.com/ratings/company-wise-ratings.jsp?txtSearch=Glenmark Pharmaceuticals Ltd"},{"rating__rating":"CRISIL AA- (Negative)","instrument":"Long Term Bank Loan","rating__source":"crisil","link":"http://www.crisil.com/ratings/company-wise-ratings.jsp?txtSearch=Glenmark Pharmaceuticals Ltd"},{"rating__rating":"CRISIL A1+","instrument":"Short-Term Loan","rating__source":"crisil","link":"http://www.crisil.com/ratings/company-wise-ratings.jsp?txtSearch=Glenmark Pharmaceuticals Ltd"},{"rating__rating":"CRISIL AA- (Negative)","instrument":"Working Capital Demand Loan","rating__source":"crisil","link":"http://www.crisil.com/ratings/company-wise-ratings.jsp?txtSearch=Glenmark Pharmaceuticals Ltd"}],"annualreport_set":[{"source":"bse","report_date":2017,"link":"http://www.bseindia.com/bseplus/AnnualReport/532296/5322960317.pdf"},{"source":"bse","report_date":2016,"link":"http://www.bseindia.com/bseplus/AnnualReport/532296/5322960316.pdf"},{"source":"bse","report_date":2015,"link":"http://www.bseindia.com/bseplus/AnnualReport/532296/5322960315.pdf"},{"source":"bse","report_date":2014,"link":"http://www.bseindia.com/bseplus/AnnualReport/532296/5322960314.pdf"},{"source":"bse","report_date":2013,"link":"http://www.bseindia.com/bseplus/annualreport/532296/5322960313.pdf"},{"source":"nse","report_date":2013,"link":"http://nseindia.com/annual_reports/AR_382_GLENMARK_2012_2013_08072013120035.zip"},{"source":"bse","report_date":2012,"link":"http://www.bseindia.com/bseplus/annualreport/532296/5322960312.PDF"},{"source":"bse","report_date":2011,"link":"http://www.bseindia.com/bseplus/annualreport/532296/5322960311.pdf"},{"source":"nse","report_date":2011,"link":"http://nseindia.com/annual_reports/AR_GLENMARK_2010_2011_20062012120105.zip"},{"source":"bse","report_date":2010,"link":"http://www.bseindia.com/bseplus/annualreport/532296/5322960310.pdf"},{"source":"nse","report_date":2010,"link":"http://nseindia.com/annual_reports/AR_GLENMARK_2009_2010_03092010120000.zip"}],"announcement_set":[{"ann_date":"05 Apr 2018","announcement":"Statement Of Investor Complaints For The Quarter Ended March 2018","link":"https://www.bseindia.com/corporates/anndet_new.aspx?newsid=5cbce862-3cf1-4d3c-b458-6a50fb90f4b5"},{"ann_date":"04 Apr 2018","announcement":"Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2018","link":"https://www.bseindia.com/corporates/anndet_new.aspx?newsid=1c239c20-b8b1-4ac2-a56c-95e345d76891"},{"ann_date":"04 Apr 2018","announcement":"Announcement under Regulation 30 (LODR)-Press Release / Media Release","link":"https://www.bseindia.com/corporates/anndet_new.aspx?newsid=4f941b58-2985-4b44-a4bc-90ab96121a52"},{"ann_date":"27 Mar 2018","announcement":"Announcement under Regulation 30 (LODR)-Press Release / Media Release","link":"https://www.bseindia.com/corporates/anndet_new.aspx?newsid=e5035728-c0e2-434d-a447-61b1c0106ed5"},{"ann_date":"06 Mar 2018","announcement":"Announcement under Regulation 30 (LODR)-Press Release / Media Release","link":"https://www.bseindia.com/corporates/anndet_new.aspx?newsid=2489e9b3-325b-49c1-b51c-28b149a30fa4"}],"warehouse_set":{"high_price":915.9,"low_price":517.05,"sales_growth":-14.22,"current_price":563.6,"dividend_yield":0.35,"face_value":1.0,"id":1048,"sales_growth_3years":49.43,"profit_growth_5years":54.28,"average_return_on_equity_3years":26.76,"book_value":362.5,"status":"Active","pair_url":"/company/GLENMARK/consolidated","sales_growth_10years":21.3,"average_return_on_equity_10years":22.38,"profit_growth":-49.95,"market_capitalization":15904.42,"profit_growth_10years":22.12,"price_to_earning":12.48,"industry":"Pharmaceuticals","analysis":{"remarks":["Some businesses are provided tax benefits to encourage their development"],"bad":["Though the company is reporting regular profits, it is not paying out tax"],"good":["Company has good consistent profit growth of 54.28% over 5 years","Company has a good return on equity (ROE) track record: 3 Years ROE 26.76%"]},"result_type":"sa","profit_growth_3years":74.89,"sales_growth_5years":38.55,"return_on_equity":27.64,"average_return_on_equity_5years":24.64},"id":1144,"name":"Glenmark Pharmaceuticals Ltd"}
